Learn More
Medchemexpress LLC 4-((4-oxo-2-thioxo-3-(3-(trifluoromethyl)benzyl)thiazolidin-5-ylidene)methyl)benzoic acid | 1073612-91-5 | MFCD31619349 | 99.6% | 423.43 g/mol | C19H12F3NO3S2 | 25 MG

Supplier: Medchemexpress LLC HY10366625MG
CY-09 is a selective, direct inhibitor of the NLRP3 inflammasome that binds the ATP-binding motif of the NLRP3 NACHT domain and inhibits NLRP3 ATPase activity, suppressing inflammasome assembly and activation. Supplied as a high-purity solid for research use.
- Selective NLRP3 inhibitor targeting the ATP-binding motif
- Inhibits NLRP3 ATPase activity to block inflammasome activation
- High purity solid form for research applications
- Light yellow to yellow appearance
- Stable when stored at recommended low temperatures
- Available in small research sizes, including 25 mg
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.